Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: Combined effects on epidermal and immunologic activation

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 451-457

  Hodak, Emmilia ^a,c   Gottlieb, Alice B ^b   Segal, Tsvi ^a   Politi, Yael ^a   Maron, Lea ^a   Sulkes, Jaqueline ^a   David, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; KERATIN;

ADULT; AGED; ARTICLE; BATH; CLIMATOTHERAPY; CLIMATOTHERAPY AT THE DEAD SEA; CLINICAL ARTICLE; DISEASE SEVERITY; EPIDERMIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; KERATINOCYTE; MALE; PRIORITY JOURNAL; PSORIASIS; REMISSION; SCORING SYSTEM; SEA; SKIN BIOPSY; SUNLIGHT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

EID: 0041355377     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00916-2     Document Type: Article

References (20)

1. Dostrovsky A, Sagher E. Preliminary report: the therapeutic effects of the hot springs of Zohar on some skin diseases. Harefuah 1959;57:143-5.
2. Goldberg LH, Sagher E. Psoriasis treatment at the Dead Sea. Cutis 1975;16:61-2.
3. Avrach WW. Climatotherapy at the Dead Sea. In: Farber EM, editor. Psoriasis proceedings of the second international symposium 1976. New York: Yorke Medical Books; 1977. p. 258.
4. Abels DJ, Kattan-Byron J. Psoriasis treatment at the Dead Sea: a natural selective ultraviolet phototherapy. J Am Acad Dermatol 1985;12:639-43.
5. Even-Paz Z, Shani J. The Dead Sea and psoriasis: historical and geographic background. Int J Dermatol 1989;28:1-9.
6. Abels DJ, Rose T, Bearman J. Psoriasis at a Dead Sea dermatology clinic. Int J Dermatol 1995;34:134-7.
7. Harari M, Shani J. Demographic evaluation of successful antipsoriatic climatotherapy at the Dead Sea (Israel) DMZ clinic. Int J Dermatol 1997;36:304-8.
8. Shani J, Harari M, Hristakieva E, Seidl V, Bar-Giyora J. Dead Sea climatotherapy versus other modalities of treatment for psoriasis: comparative cost effectiveness. Int J Dermatol 1999;38:252-62.
9. Even-Paz Z, Guman R, Kipnis V, Abels DJ, Efron D. Dead Sea sun versus Dead Sea water in the treatment of psoriasis. J Dermatol Treat 1996;7:83-6.
10. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with new retinoid. Dermatologica 1978;157:238-44.
11. Vallat VP, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftler N, et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 1994;180:283-96.
12. Mansbridge JN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 1987;89:253-63.
13. Coven TR, Murphy FP, Gilleaudeau P, Cardinale I, Krueger JG. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Arch Dermatol 1998;134:1263-8.
14. Krueger JG, Wolf TJ, Nabeya R, Vallat VP, Gilleaudeau P, Heftler N, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995;182:2057-68.
15. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, et al. 312 nanometer ultraviolet B light (narrowband UVB) induces apoptosis in T cells within psoriatic lesions. J Exp Med 1999;189:711-8.
16. Even-Paz Z. Dermatology at the Dead Sea spas. Isr J Med Sci 1996;32:11-5.
17. Kushelevsky AP, Slifkin MA. Ultraviolet measurements at the Dead Sea and Beer Sheva. Isr J Med Sci 1975;11:488-90.
18. Frentz G, Olsen JH, Avrach WW. Malignant tumours and psoriasis: climatotherapy at the Dead Sea. Br J Dermatol 1999;141: 1088-91.
19. David M, Adder B, Zucrov B, Segal Z, Pavloski F, Hershko K, et al. Actinic damage among psoriatic patients who were treated at the Dead Sea. Presented at: 26th Annual Meeting of the Israel Society of Dermatology and Venereology; June 6, 2002; Ein Bokek, Dead Sea, Israel.
20. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysis. Arch Dermatol 1998;134:1582-5.